Home/Filings/4/0001127602-12-008159
4//SEC Filing

Goldsmith Bruce A 4

Accession 0001127602-12-008159

CIK 0001097264other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 5:43 PM ET

Size

6.4 KB

Accession

0001127602-12-008159

Insider Transaction Report

Form 4
Period: 2012-02-23
Goldsmith Bruce A
VP, Corporate Development
Transactions
  • Sale

    Common Stock

    2012-02-23$1.58/sh2,500$3,958176,759 total
  • Sale

    Common Stock

    2012-02-24$1.54/sh575$888176,184 total
Footnotes (2)
  • [F1]These shares are being sold pursuant to a 10b5-1 plan for Bruce A. Goldsmith in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 22, 2012.
  • [F2]These shares are being sold pursuant to a 10b5-1 plan for Bruce A. Goldsmith in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 23, 2012.

Issuer

ALLOS THERAPEUTICS INC

CIK 0001097264

Entity typeother

Related Parties

1
  • filerCIK 0001500322

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:43 PM ET
Size
6.4 KB